MAO Inhibitors and Food Interactions
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Dr. J Alexander Bodkin, Chief of the Clinical Psychopharmacology Research Program at the McLean Hospital and Assistant Professor in the Department of Psychiatry at Harvard Medical School, discusses the science behind MAO inhibitors and food interactions with host Dr. Leslie Lundt.
Overview
Dr. J Alexander Bodkin, Chief of the Clinical Psychopharmacology Research Program at the McLean Hospital and Assistant Professor in the Department of Psychiatry at Harvard Medical School, discusses the science behind MAO inhibitors and food interactions with host Dr. Leslie Lundt.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Phase 3 study results of plozasiran in patients with FCS
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
NYHA FC and Finerenone Response: Clinical Trial Insights
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?